Effects of a leukotriene receptor antagonist on exhaled leukotriene E4 and prostanoids in children with asthma
- 1 August 2006
- journal article
- clinical trial
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 118 (2) , 347-353
- https://doi.org/10.1016/j.jaci.2006.04.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Allergy and asthmaJournal of Allergy and Clinical Immunology, 2005
- Exhaled breath condensate cysteinyl leukotrienes are increased in children with exercise-induced bronchoconstrictionJournal of Allergy and Clinical Immunology, 2005
- Advances in pediatric and adult asthmaJournal of Allergy and Clinical Immunology, 2005
- Comparison Study between the Mechanisms of Allergic Asthma Amelioration by a Cysteinyl-Leukotriene Type 1 Receptor Antagonist Montelukast and MethylprednisoloneThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Characterization of within-subject responses to fluticasone and montelukast in childhood asthmaJournal of Allergy and Clinical Immunology, 2005
- Isoprostanes: markers and mediators of oxidative stressThe FASEB Journal, 2004
- Effects of inhaled corticosteroids on exhaled leukotrienes and prostanoids in asthmatic childrenJournal of Allergy and Clinical Immunology, 2004
- Indirect monitoring of lung inflammationNature Reviews Drug Discovery, 2002
- Regulation of Leukotrienes in the Management of Asthma: Biology and Clinical TherapyAnnual Review of Medicine, 2001
- STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENTThe Lancet, 1986